Merck, the global pharmaceutical and chemical company that developed the osteoporosis drug, Fosamax, has recently lost two cases. The most recent one – Scheinberg vs. Merck – puts Merck on the hot seat for failing to warn the consumer adequately about the extremely harmful side effects of Fosamax. To read more about it, check out this timely article from SaveOurBones.com:
http://saveourbones.com/fda-regulators-look-out-for-merck-and-more/
Tags: Fosamax, Merck, Osteoporosis drugs
